Pathology - Research and Practice, Год журнала: 2025, Номер unknown, С. 155937 - 155937
Опубликована: Март 1, 2025
Язык: Английский
Pathology - Research and Practice, Год журнала: 2025, Номер unknown, С. 155937 - 155937
Опубликована: Март 1, 2025
Язык: Английский
Elsevier eBooks, Год журнала: 2025, Номер unknown, С. 389 - 510
Опубликована: Янв. 1, 2025
Язык: Английский
Процитировано
0Vaccines, Год журнала: 2025, Номер 13(3), С. 285 - 285
Опубликована: Март 7, 2025
Cell-derived, nanoscale extracellular vesicles (EVs) have emerged as promising tools in diagnostic, therapeutic, and vaccine applications. Their unique properties including the capability to encapsulate diverse molecular cargo well versatility surface functionalization make them ideal candidates for safe effective vehicles deliver a range of biomolecules gene editing cassettes, therapeutic proteins, glycans, glycoconjugate vaccines. In this review, we discuss recent advances development EVs derived from mammalian bacterial cells use delivery carbohydrate-based protein therapeutics We highlight key innovations EVs’ design, characterization, deployment treating diseases Alzheimer’s disease, infectious diseases, cancers. challenges their clinical translation provide perspectives future within biopharmaceutical research landscape.
Язык: Английский
Процитировано
0Pathology - Research and Practice, Год журнала: 2025, Номер unknown, С. 155937 - 155937
Опубликована: Март 1, 2025
Язык: Английский
Процитировано
0